# [FOXP1]

## Mutation tier

|Entity|Tier|
|------|----|
|DLBCL |2   |

## Mutation incidence

|Entity|study         |frequency (%)|
|------|--------------|-------------|
|DLBCL |GAMBL genomes |0.7          |
|DLBCL |Schmitz cohort|1.9          |
|DLBCL |Reddy cohort  |2.1          |
|DLBCL |Chapuy cohort |3.0          |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   |1.218           | 9.469          |
|DLBCL |Yes |No                   |7.387           |17.777          |
|FL    |Yes |No                   |0.000           | 0.000          |

## aSHM regions

|chr_name|hg19_start|hg19_end|region   |regulatory_comment|
|--------|----------|--------|---------|------------------|
|chr3    |71104986  |71119518|TSS-4    |active_promoter   |
|chr3    |71176427  |71180960|TSS-3    |active_promoter   |
|chr3    |71350633  |71357665|TSS-2    |active_promoter   |
|chr3    |71503103  |71504870|intron-1b|intron            |
|chr3    |71550753  |71551478|intron-1a|intron            |
|chr3    |71626341  |71635648|TSS-1    |active_promoter   |

> [!NOTE]
> First described in DLBCL in 2017 by [Reddy A](https://pubmed.ncbi.nlm.nih.gov/28985567)